Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ZIMMER BIOMET HOLDINGS, INC.ZBH · Entity 3278 | See remarks below. | June 01, 2026 | June 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ZIMMER BIOMET HOLDINGS, INC.
Report date June 01, 2026 · Filed June 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 1,857 |
Reported balance
After 2026-06-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-01 · Grant · Acquired 1,857 · Balance 1,857 F1: Each RSU represents a contingent right to receive one share of Company common stock. F2: Vests annually over three years in increments of one-third each year, commencing June 1, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: Each RSU represents a contingent right to receive one share of Company common stock.
F2: Vests annually over three years in increments of one-third each year, commencing June 1, 2027.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 01, 2026 Filed Jun 3, 2026 20:31 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantRestricted Stock Units · Derivative | 1,857 | $0.00 | $0.00 |
DisclosureSEC source: 0002059755-26-000006 · form4-06032026_080620.xml · derivative · entry 1 Noor Jehanzeb · CIK 0002059755 · See remarks below. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,857 Underlying: Common Stock · 1,857 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. F2 · derivative.exercise_date: Vests annually over three years in increments of one-third each year, commencing June 1, 2027. F2 · derivative.expiration_date: Vests annually over three years in increments of one-third each year, commencing June 1, 2027. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 20:03 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionRestricted Stock Units · Derivative | 6,626 | $0.00 | $0.00 |
DisclosureSEC source: 0002059755-26-000004 · form4-04032026_080411.xml · derivative · entry 3 Noor Jehanzeb · CIK 0002059755 · See remarks below. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,249 Underlying: Common Stock · 6,626 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. F4 · derivative.exercise_date: One-third of the RSUs vested on April 1, 2026. The remaining RSUs vest one-half on each of April 1, 2027 and April 1, 2028. F4 · derivative.expiration_date: One-third of the RSUs vested on April 1, 2026. The remaining RSUs vest one-half on each of April 1, 2027 and April 1, 2028. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 20:03 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Tax withholdingCommon Stock | 1,677 | $90.67 | $152,053.59 |
DisclosureSEC source: 0002059755-26-000004 · form4-04032026_080411.xml · nonDerivative · entry 2 Noor Jehanzeb · CIK 0002059755 · See remarks below. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,151 F2 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding on the vesting of restricted stock units ("RSUs"). Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 20:03 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 6,626 | $0.00 | $0.00 |
DisclosureSEC source: 0002059755-26-000004 · form4-04032026_080411.xml · nonDerivative · entry 1 Noor Jehanzeb · CIK 0002059755 · See remarks below. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,828 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 202 shares acquired under the Employee Stock Purchase Plan on December 31, 2025. Read SEC document |
| February 20, 2026 Filed Feb 25, 2026 02:04 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantRestricted Stock Units · Derivative | 10,076 | $0.00 | $0.00 |
DisclosureSEC source: 0002059755-26-000002 · form4-02252026_020208.xml · derivative · entry 1 Noor Jehanzeb · CIK 0002059755 · See remarks below. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,076 Underlying: Common Stock · 10,076 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. F2 · derivative.exercise_date: Vests annually over three years in increments of one-third each year, commencing February 20, 2027. F2 · derivative.expiration_date: Vests annually over three years in increments of one-third each year, commencing February 20, 2027. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 21:06 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantRestricted Stock Units · Derivative | 19,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-006996 · form4.xml · derivative · entry 1 Noor Jehanzeb · CIK 0002059755 · See remarks below. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,875 Underlying: Common Stock · 19,875 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F2 · derivative.exercise_date: Vests annually over three years in increments of one-third each year, commencing April 1, 2026. F2 · derivative.expiration_date: Vests annually over three years in increments of one-third each year, commencing April 1, 2026. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.